Hygeia Healthcare Holdings Co., Ltd.: management transactions · Hong Kong · HKEX HKEX:hygeia-healthcare-holdings-co-ltd HK HK · HKEX Mcap 6.8Bn€ Healthcare
Browse the full directors' dealings record of Hygeia Healthcare Holdings Co., Ltd., a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Hygeia Healthcare Holdings Co., Ltd. has logged 9 reports. Market capitalisation: €6.8bn. The latest transaction was disclosed on 14 May 2026 — Purchase. Among the most active insiders: ZHU Yiwen. The full history is accessible without an account.
Financial data FY ended December 2025 · cache
Analyst consensus
15 analysts · 11.58 € Target 17.56 €(+59%) 25.01 €
Income statement
Revenue 4.01 Bn€
Gross profit 1.02 Bn€ 26% margin
Net income 164.5 M€ 4.1% margin
Valuation
PER (trailing) 35.6x
PER (forward) 10.8x
P/Book 0.9x
Beta 0.45
Balance sheet & cash
Market cap 6.79 Bn€
Total debt 2.45 Bn€
Free Cash Flow 466.4 M€
Debt / Equity 36%
Profitability & ownership
ROE 2.4%
ROA 4.0%
% insiders 47.2%
% institutions 21.1%
Last declaration on 14 May 2026
Declarations 9 total
Executives ● Purchase11 HKEX
€1m 1,138,200 shares @ €1.2665 0.021% mcap 31.7% of flow
HKEX:DA20260514E00356 · 14 May 2026
Ideal exit: 8 Feb 2027 (T+270) Executives ● Purchase16 HKEX
€2m 1,600,000 shares @ €1.292 0.030% mcap 66.6% of flow
HKEX:DA20260512E00318 · 11 May 2026
Ideal exit: 5 Feb 2027 (T+270) Executives ● Purchase8 HKEX
€671,438 519,000 shares @ €1.2937 0.0099% mcap 21.6% of flow
HKEX:DA20260512E00316 · 8 May 2026
Ideal exit: 2 Feb 2027 (T+270) Executives ● Purchase5 HKEX
€39,031 30,400 shares @ €1.2839 0.0006% mcap 1.3% of flow
HKEX:DA20260509E00024 · 7 May 2026
Ideal exit: 1 Feb 2027 (T+270) Executives ● Purchase6 HKEX
€325,506 260,400 shares @ €1.25 0.0048% mcap 10.5% of flow
HKEX:DA20260509E00023 · 6 May 2026
Ideal exit: 31 Jan 2027 (T+270) Executives ● Purchase14 HKEX
€2m 1,600,000 shares @ €1.292 0.030% mcap 45.5% of flow
HKEX:DA20260511E00286 · 11 May 2026
Ideal exit: 5 Feb 2027 (T+270) Executives ● Purchase7 HKEX
€671,438 519,000 shares @ €1.2937 0.0099% mcap 14.8% of flow
HKEX:DA20260508E00333 · 8 May 2026
Ideal exit: 2 Feb 2027 (T+270) Executives ● Purchase5 HKEX
€39,031 30,400 shares @ €1.2839 0.0006% mcap 0.9% of flow
HKEX:DA20260508E00317 · 7 May 2026
Ideal exit: 1 Feb 2027 (T+270) Executives ● Purchase6 HKEX
€325,506 260,400 shares @ €1.25 0.0048% mcap 7.2% of flow
HKEX:DA20260506E00350 · 6 May 2026
Ideal exit: 31 Jan 2027 (T+270)